US2300311063
US2300311063
Cullinan Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 241.648.000 | 196.919.000 | 22.7% | |
| Operating Income | -241.648.000 | -196.919.000 | 22.7% |
| Pretax Income | -219.879.000 | -167.458.000 | 31.3% |
| Net Income Common Stockholders | -219.879.000 | -167.383.000 | 31.4% |
| -- | -- | -- | |
| -- | -- | -- |